Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 7001 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Novo Nordisk A/S - share repurchase programme

Read more ››
By: GlobeNewswire - 04 Mar 2024

Vaxil Bio Proposed Reverse Takeover with Copper Bullet Terminated and Update of Research Activities

Read more ››
By: GlobeNewswire - 04 Mar 2024

Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Screening and More in 11 Presentations at ACMG 2024

Read more ››
By: GlobeNewswire - 04 Mar 2024
Related companies:  Baylor Genetics

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

Read more ››
By: GlobeNewswire - 04 Mar 2024

Resolutions from the Extraordinary Shareholders’ Meeting 2024

Read more ››
By: GlobeNewswire - 04 Mar 2024
Related companies:  Novozymes A/S

Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas

Read more ››
By: GlobeNewswire - 04 Mar 2024
Related companies:  Oxurion NV

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Read more ››
By: GlobeNewswire - 04 Mar 2024
Related companies:  Genmab A/S

Better Choice to Explore Non-Equity Related Capital Solutions to Fund the R&D of its Domestic Animal Targeted GLP1 Supplement

Read more ››
By: GlobeNewswire - 04 Mar 2024

Landmark Clinical Approval for YOLT-201 Obtained by the NMPA

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024
Related companies:  YolTech Therapeutics Co., Ltd.

Henlius Forecasts Profit in 2023: Achieving first full year of profitability, and ushering in a new phase of high-quality development

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024
Related companies:  Shanghai Henlius Biotech Co., Ltd.

Neurophet introduces AI-powered brain imaging analysis technology at AD/PD 2024

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024
Related companies:  NEUROPHET Inc.

Cyient Partners with MassMedic to Accelerate MedTech Innovation

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024

Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024
Related companies:  Inspira Technologies

Global Autoimmune Disease Diagnostics Market Poised for Growth, Reaching $17.9 Billion by 2028: BCC Research

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024

BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024
Related companies:  Becton, Dickinson and Company

BioLineRx Strengthens Intellectual Property Estate with Notice of Allowance for U.S. Patent Covering Method of Manufacturing Motixafortide (BL-8040) Suitable for Large Scale Production

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024

Cloud Peritus and Junction Health Forge Strategic Salesforce Partnership

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024
Related companies:  Cloud Peritus Inc.

DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024
Related companies:  Durect Corporation

Avidity Biosciences Announces Positive AOC 1001 Long-term Data Showing Reversal of Disease Progression in People Living with Myotonic Dystrophy Type 1 Across Multiple Endpoints; Same Key Endpoints Agreed for Phase 3 HARBOR™ Trial

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024
Related companies:  Avidity Biosciences, Inc.

Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024
Related companies:  Acurx Pharmaceuticals, LLC
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑